Cholestatic jaundice during infancy: experience at a tertiary-care center in Bangladesh

A S M Bazlul Karim1, M Kamal

  • 1Department of Pediatric Gastroenterology and Nutrition, B S M Medical University, Shabagh, Dhaka, Bangladesh. karimb@bangla.net

Insights

Neonatal hepatitis and biliary atresia are common causes of infant cholestatic jaundice. Early diagnosis is crucial, though many infants present late, impacting timely management of neonatal cholestasis.

Area of Science:

  • Pediatrics
  • Neonatology
  • Hepatology

Background:

  • Cholestatic jaundice in early infancy presents diagnostic challenges.
  • Early diagnosis is critical for effective management of neonatal cholestatic disorders.
  • This study investigates the causes and clinical features of neonatal cholestasis in Bangladesh.

Purpose of the Study:

  • To determine the etiology of neonatal cholestatic disorders.
  • To describe the clinical profile of infants with cholestatic jaundice.
  • To highlight diagnostic and management challenges in a developing country context.

Main Methods:

  • Retrospective study of 62 infants with cholestatic jaundice (onset before 3 months, duration > 2 weeks).
  • Data collected from a tertiary-care hospital in a developing country.
  • Analysis of clinical presentation and etiological factors.

Main Results:

  • Neonatal hepatitis (35.5%, including TORCH infections and urinary infections) was the most frequent cause.
  • Biliary atresia (25.8%) and idiopathic neonatal hepatitis (24.2%) were also common.
  • Mean age at presentation was 3.5 months; 87.5% of biliary atresia cases presented within 14 days.

Conclusions:

  • Neonatal hepatitis, biliary atresia, and idiopathic neonatal hepatitis are primary causes of neonatal cholestasis.
  • Despite early onset of jaundice, a significant delay in presentation was observed.
  • Timely diagnosis and intervention remain critical for improving outcomes in neonatal cholestasis.
Abstract

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...